| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |